The latest news and opinion, plus the biggest stories from the Guardian

The Guardian Today US | The Guardian

Support independent journalism

The Guardian Today US
News
Israel launches ground offensive deep inside Gaza City
Gaza  
Israel launches ground offensive deep inside Gaza City
Overnight advance aimed at ‘dismantling Hamas’s grip’ as Israel accused of genocide in UN human rights report
Media  
Donald Trump files $15bn lawsuit against New York Times
Russia-Ukraine war  
Russia has network of 200 camps for ‘brainwashing’ Ukrainian children – report
Charlie Kirk shooting  
Progressive groups fear ‘McCarthy era’ attacks in wake of Charlie Kirk shooting
Health  
Mississippi declares infant deaths emergency as CDC program that could have helped is halted
In focus
Why have top Democratic leaders failed to endorse rising star Zohran Mamdani?
Democrats  
Why have top Democratic leaders failed to endorse rising star Zohran Mamdani?
New York’s Governor Kathy Hochul has finally lent the city’s mayoral nominee her support – but the party’s top congressional leaders, both New Yorkers, have not
Ice  
California nurses decry Ice presence at hospitals: ‘Interfering with patient care’
Brazil  
‘Diplomatic abuse’: Brazil minister on US revoking his 10-year-old daughter’s visa
 Paid for by Pacaso   
Former Zillow exec opens door to $1.3T market
Austin Allison sold his first company for $120M. He later served as an executive for Zillow. But both companies reached massive valuations before regular people could invest.

''I always wished everyday investors could have shared in their early success,'' Allison later said. So he built Pacaso differently.

Pacaso brings co-ownership to the $1.3T vacation home market, earning $110M+ in gross profit in under 5 years. No wonder the same early investors who backed Uber, Venmo, and eBay already invested in Pacaso.

Now, after adding 10 new international destinations, Pacaso is hitting their stride. They even reserved the Nasdaq ticker PCSO.

And unlike his previous stops, you can invest in Pacaso as a private company. But you don’t have time to waste. Invest before Pacaso’s opportunity ends on September 18th.

*This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the company will go public. Listing on the Nasdaq is subject to approvals.
Features
‘I love you too!’ My family’s creepy, unsettling week with an AI toy
Technology  
‘I love you too!’ My family’s creepy, unsettling week with an AI toy
The cuddly chatbot Grem is designed to ‘learn’ your child’s personality, while every conversation they have is recorded, then transcribed by a third party. It wasn’t long before I wanted this experiment to be over ...
Coffee  
How I brew cafe-quality coffee anywhere, from campsite to carry-on
Opinion
Americans have 400 days to save their democracy
Americans have 400 days to save their democracy
Jews and Israel are not the same. Equating them is a propaganda technique
Sports
NFL  
Bengals think they’re playing fantasy football, and Burrow keeps paying the price
Bengals think they’re playing fantasy football, and Burrow keeps paying the price
World Athletics Championships live  
Women’s 1500m, men’s 110m hurdles and more
Culture
Art  
‘Trump is a defecating fly on a camel’s back’: Palestinian artist Samia Halaby on being banned, exiled – and now celebrated
‘Trump is a defecating fly on a camel’s back’: Palestinian artist Samia Halaby on being banned, exiled – and now celebrated
Podcasts  
‘We’re insanely hubristic’: how The Rest Is History became the world’s biggest history podcast
Lifestyle
Memory  
Is a memory palace actually useful? It helped me memorize the first 20 digits of pi
 Is a memory palace actually useful? It helped me memorize the first 20 digits of pi
Travel  
Steam baths and seaweed safaris on Sweden’s spa island
You may have missed
‘Americans should be alarmed’: Experts say loss of expertise at CDC will harm US health
US healthcare  
‘Americans should be alarmed’: Experts say loss of expertise at CDC will harm US health